ReportsWeb- Molecular Diagnostics Global Market 2016 by Applic

Molecular Diagnostics Global Market 2016 by Application, Region,
Technology, Value, Analysis and Forecast to 2020
ReportsWeb.com published “Molecular Diagnostics Market” from its database. The report covers the
market landscape and its growth prospects over the coming years. The report also includes a discussion
of the key vendors operating in this market.
Diagnosis is the identification of the nature and cause of a certain phenomenon. It involves two different
types of testing method: in vivo and in vitro diagnostics. In vitro diagnostics (IVD) are the medical tests
which are intended to perform diagnoses from sample of body fluids in a controlled environment
outside a living organism. In vitro diagnostic (IVD) tests are performed to conduct diagnoses from assays
in a test tube, or in a controlled environment outside a living organism.
Molecular Diagnostics is a technology used in the process of in vitro diagnosis. Molecular diagnostics
involves the measurement of DNA, RNA, proteins or metabolites in order to detect genotypes,
mutations or biochemical changes in the body. Molecular diagnostics market is escalating beyond the
identification of infections. It is becoming an essential part of disease management and therapy. The
variety of technologies used in molecular diagnostics has transformed clinical laboratory medicine. The
market is further expected to see a robust growth with increased research and development.
For more information about this report: http://www.reportsweb.com/global-molecular-diagnostics-
market-2016-2020
The global molecular diagnostics market is expected to see innovation driven growth. With recent
outbreak of infectious diseases like Ebola and swine flu, they would require accurate diagnostics, which
will instigate the growth of the molecular diagnostics technology in the future, thereby posing
tremendous growth potential for the market. Asia-Pacific is expected to register the highest growth rate
in expansion of molecular diagnostics in the coming years.
The key factors driving growth of the MD market includes fast approvals for companion diagnostics
reagents, increase in emergence of infectious disease, innovation and technical development, rising
ageing population, and escalating global healthcare expenditure. However, there are certain factors
hindering the growth of the market like high initial cost, obligation of skilled labor, and lack of proper
healthcare infrastructure. The major trends featuring the market includes increasing clinical
microbiological laboratories in developing nations, next generation sequencing, and increase in sale of
point of care devices.